The short version of actin binding fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-01-25. Anything still debated is marked as such rather than presented as settled.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
| Property | Value | Notes |
|---|---|---|
| Generic designation | Synthetic thymosin beta-4 N-terminal fragment | Peptide nomenclature varies by supplier |
| Peptide length | Approximately 17 amino acid residues | Reported length sometimes differs between sources |
| N-terminal modification | Acetyl group | Affects mass and chromatographic behaviour |
| Compound class | Small synthetic peptide | Not a small-molecule drug |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Naming is inconsistent in popular media |
Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
=== Prioritisation of foodborne pathogens === The Food and Agriculture Organization of the United Nations and The World Health Organization have published a global ranking of foodborne parasites using a multicriteria ranking tool concluding that Taenia solium was the most relevant, followed by Echinococcus granulosus, Echinococcus multilocularis, and Toxoplasma gondii. The same method was used regionally to rank the most important foodborne parasites in Europe ranking Echinococcus multilocularis of highest relevance, followed by Toxoplasma gondii and Trichinella spiralis.
Freeman's sole film release of 2010 was Red with co-stars Bruce Willis, Helen Mirren, and John Malkovich. Red is loosely adapted from the comic-book series Red, created by Warren Ellis and Cully Hamner and published by the DC Comics imprint Homage. Freeman plays CIA mentor Joe, who helps retired fellow agent Frank (Willis) to uncover some assassins. The film was a critical and commercial success; writing for Melbourne's The Age, Jim Schembri praised Freeman and the cast who "bring an infectious comic energy to their roles". Besides film, Freeman worked on other projects. In January 2010, he replaced Walter Cronkite as the voiceover introduction to the CBS Evening News presented by Katie Couric. CBS gave the need for consistency in introductions for regular news broadcasts and special reports as the basis for the change. Deborah Myers, head of Science Channel, approached Freeman to be the presenter of Through the Wormhole (2010–17). She had heard that he was "really interested in space and the universe", and the pair agreed to develop the series together. In 2011, Freeman narrated the fantasy Conan the Barbarian and appeared in the family drama Dolphin Tale, as prosthetic specialist Dr. McCarthy. Returning to theater in 2011, Freeman was featured with John Lithgow in the Broadway debut of Dustin Lance Black's play, 8, a staged reenactment of Perry v. Brown, the federal trial that overturned California's Proposition 8 ban on same-sex marriage. Freeman played Attorney David Boies.
==== TP0624 ==== Outer Membrane Protein A (OmpA) domain-containing proteins are necessary for maintaining structural integrity in gram-negative bacteria. These domains contain peptidoglycan binding sites which creates a "structural bridge between the peptidoglycan layer and the outer memebrane." The protein TP0624 found in T. pallidum has been proposed to facilitate this structural link, as well as interactions between outer membrane proteins and corresponding domains on the thin peptidoglycan layer.
== Matrix-assisted ionization == Matrix-assisted ionization is an ionization method in mass spectrometry that creates ions via the creation of particles at atmospheric pressure and transfer to the vacuum of the mass analyzer.
Sources: en.wikipedia.org
=== Legal status === In Canada, amphetamines are in Schedule I of the Controlled Drugs and Substances Act, and can only be obtained by prescription. In Japan, the use, production, and import of any medicine containing amphetamines is prohibited. In South Korea, amphetamines are prohibited. In Taiwan, amphetamines including Adderall are Schedule 2 drugs with a minimum five-year prison term for possession. On the contrary, Ritalin can be legally prescribed as a form of treatment of ADHD. In Thailand, amphetamines are classified as Type 1 Narcotics. In the United Kingdom, amphetamines are regarded as Class B drugs. The maximum penalty for unauthorized possession is five years in prison and an unlimited fine. The maximum penalty for illegal supply is 14 years in prison and an unlimited fine. In the United States, amphetamine is a Schedule II prescription drug, classified as a central nervous system (CNS) stimulant. Internationally, amphetamine is in Schedule II of the Convention on Psychotropic Substances.
The United States Army uses various personnel management systems to classify soldiers in different specialties which they receive specialized and formal training on once they have successfully completed Basic Combat Training (BCT). Enlisted soldiers are categorized by their assigned job called a Military Occupational Specialty (MOS). MOS are labeled with a short alphanumerical code called a military occupational core specialty code (MOSC), which consists of a two-digit number appended by a Latin letter. Related MOSs are grouped together by Career Management Fields (CMF). For example, an enlisted soldier with MOSC 11B works as an infantryman (his MOS), and is part of CMF 11 (the CMF for infantry). Commissioned officers are classified by their area of concentration, or AOC. Just like enlisted MOSCs, AOCs are two digits plus a letter. Related AOCs are grouped together by specific branch of the Army or by broader in scope functional areas (FA). Typically, an officer will start in an AOC of a specific branch and move up to an FA AOC. Warrant officers are classified by warrant officer military occupational specialty, or WOMOS. Codes consists of three digits plus a letter. Related WOMOS are grouped together by Army branch. The Army is currently restructuring its personnel management systems, as of 2019. Changes took place in 2004 and continued into 2013. Changes include deleting obsolete jobs, merging redundant jobs, and using common numbers for both enlisted CMFs and officer AOCs (e.g. "35" is military intelligence for both officers and enlisted).
=== JCAMP-DX === This format was one of the earliest attempts to supply a standardized file format for data exchange in mass spectrometry. JCAMP-DX was initially developed for infrared spectrometry. JCAMP-DX is an ASCII based format and therefore not very compact even though it includes standards for file compression. JCAMP was officially released in 1988. Together with the American Society for Mass Spectrometry a JCAMP-DX format for mass spectrometry was developed with aim to preserve legacy data.
Sources: en.wikipedia.org
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.
No. Thymosin beta-4 is the full-length protein of about forty-three amino acids, while the fragment covers only its beginning. The two are related but are not interchangeable in experimental or analytical terms.
The label is a catalogue designation that became common in non-technical discussion. Scientific papers usually refer to the fragment by sequence or as a thymosin beta-4 N-terminal peptide.
Standard practice is a desiccated container at −20 °C, protected from light and kept sealed between uses. Letting the vial reach room temperature before opening reduces condensation on the powder. Repeated warming and cooling of the whole container is generally avoided.